BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25636764)

  • 1. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.
    Chung Y; Kim JW; Shin KH; Kim SS; Ahn SJ; Park W; Lee HS; Kim DW; Lee KC; Suh HS; Kim JH; Shin HS; Kim YB; Suh CO
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):419-26. PubMed ID: 25636764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: the DBCG-IMN study.
    Thorsen LB; Thomsen MS; Overgaard M; Overgaard J; Offersen BV;
    Acta Oncol; 2013 Oct; 52(7):1526-34. PubMed ID: 23957621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual case review in a phase 3 randomized trial to investigate the role of internal mammary lymph node irradiation for breast cancer: Korean Radiation Oncology Group 08-06 study.
    Yoon HI; Yoon J; Chung Y; Nam CM; Cha H; Choi J; Lee J; Han HJ; Cho Y; Kim YB; Suh CO
    Radiother Oncol; 2017 Apr; 123(1):15-21. PubMed ID: 28236539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard Tangential Radiation Fields Do Not Provide Incidental Coverage to the Internal Mammary Nodes.
    Loganadane G; Kassick M; Kann BH; Young MR; Knowlton CA; Evans SB; Higgins SA; Belkacemi Y; Potenziani M; Saltmarsh N; Wilson LD; Moran MS
    Pract Radiat Oncol; 2020; 10(1):21-28. PubMed ID: 31394256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1).
    Poortmans PM; Venselaar JL; Struikmans H; Hurkmans CW; Davis JB; Huyskens D; van Tienhoven G; Vlaun V; Lagendijk JJ; Mijnheer BJ; De Winter KA; Van der Hulst MH; Van den Bogaert WF
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1399-408. PubMed ID: 11286848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
    Zhao XR; Fang H; Tang Y; Hu ZH; Jing H; Liang L; Yan XN; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Li N; Lu NN; Men K; Hu C; Zhang YH; Li YX; Wang SL
    BMC Cancer; 2021 Nov; 21(1):1185. PubMed ID: 34742270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works.
    Poortmans P; Kouloulias V; van Tienhoven G; Collette L; Struikmans H; Venselaar JL; Van den Bogaert W; Davis JB; Lambin P;
    Strahlenther Onkol; 2006 Oct; 182(10):576-82. PubMed ID: 17013570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects.
    Thorsen LB; Thomsen MS; Berg M; Jensen I; Josipovic M; Overgaard M; Overgaard J; Skogholt P; Offersen BV;
    Acta Oncol; 2014 Aug; 53(8):1027-34. PubMed ID: 24957557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification?
    Benda RK; Cendan JC; Copeland EM; Feezor RJ; Lind DS; Morris CG; Mendenhall NP
    Cancer; 2004 Feb; 100(3):518-23. PubMed ID: 14745867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental radiation dose to internal mammary lymph nodal area in carcinoma breast patients treated with forward planning intensity-modulated radiation therapy technique: A single-institute dosimetric study.
    Suryadevara A; Ahamed S; Alluri KR; Sresty NVNM
    J Cancer Res Ther; 2020; 16(6):1350-1353. PubMed ID: 33342795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
    Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
    Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmastectomy internal mammary nodal irradiation: a long-term outcome.
    Aleknavičius E; Atkočius V; Kuzmickienė I; Steponavičienė R
    Medicina (Kaunas); 2014; 50(4):230-6. PubMed ID: 25458960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study.
    Stemmer SM; Rizel S; Hardan I; Adamo A; Neumann A; Goffman J; Brenner HJ; Pfeffer MR
    J Clin Oncol; 2003 Jul; 21(14):2713-8. PubMed ID: 12860949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy of internal mammary lymph nodes in breast cancer. Principle considerations on the basis of dosimetric data.
    Sautter-Bihl ML; Hültenschmidt B; Melcher U; Ulmer HU
    Strahlenther Onkol; 2002 Jan; 178(1):18-24. PubMed ID: 11977387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal mammary node coverage: an investigation of presently accepted techniques.
    Arthur DW; Arnfield MR; Warwicke LA; Morris MM; Zwicker RD
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):139-46. PubMed ID: 10924983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of Internal Mammary Nodal Target Volumes in Breast Cancer Radiation Therapy.
    Jethwa KR; Kahila MM; Hunt KN; Brown LC; Corbin KS; Park SS; Yan ES; Boughey JC; Mutter RW
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):762-769. PubMed ID: 28244412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental radiation to uninvolved internal mammary lymph nodes in breast cancer.
    Arora D; Frakes J; Scott J; Opp D; Johnson C; Song J; Harris E
    Breast Cancer Res Treat; 2015 Jun; 151(2):365-72. PubMed ID: 25929764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we predict plan quality for external beam partial breast irradiation: results of a multicenter feasibility study (Trans Tasman Radiation Oncology Group Study 06.02).
    Kron T; Willis D; Link E; Lehman M; Campbell G; O'Brien P; Chua B
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):817-24. PubMed ID: 24064318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.